FI895333A0 - Förfarande för framställning av terapeutiskt användbara pyrrolokinolin-, -bensotiazin-, -akridin-, -fenoxazin- och -fenotiazinderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara pyrrolokinolin-, -bensotiazin-, -akridin-, -fenoxazin- och -fenotiazinderivat

Info

Publication number
FI895333A0
FI895333A0 FI895333A FI895333A FI895333A0 FI 895333 A0 FI895333 A0 FI 895333A0 FI 895333 A FI895333 A FI 895333A FI 895333 A FI895333 A FI 895333A FI 895333 A0 FI895333 A0 FI 895333A0
Authority
FI
Finland
Prior art keywords
pyrroloquinoline
benzothiazine
phenoxazine
acridine
preparation
Prior art date
Application number
FI895333A
Other languages
English (en)
Finnish (fi)
Other versions
FI96315C (sv
FI96315B (sv
Inventor
Banavara Lakshmana Mylari
Joseph George Lombardino
James Michael Mcmanus
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI895333A0 publication Critical patent/FI895333A0/sv
Application granted granted Critical
Publication of FI96315B publication Critical patent/FI96315B/sv
Publication of FI96315C publication Critical patent/FI96315C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI895333A 1988-03-11 1989-11-09 Förfarande för framställning av terapeutiskt användbara pyrrolokinolin-, -bensotiazin-, -akridin-, -fenoxazin- och -fenotiazinderivat FI96315C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8800781 1988-03-11
PCT/US1988/000781 WO1989008654A1 (en) 1988-03-11 1988-03-11 Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds

Publications (3)

Publication Number Publication Date
FI895333A0 true FI895333A0 (sv) 1989-11-09
FI96315B FI96315B (sv) 1996-02-29
FI96315C FI96315C (sv) 1996-06-10

Family

ID=22208596

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895333A FI96315C (sv) 1988-03-11 1989-11-09 Förfarande för framställning av terapeutiskt användbara pyrrolokinolin-, -bensotiazin-, -akridin-, -fenoxazin- och -fenotiazinderivat

Country Status (15)

Country Link
EP (1) EP0332364A3 (sv)
JP (1) JPH0676408B2 (sv)
KR (1) KR910002565B1 (sv)
AU (1) AU605410B2 (sv)
CA (1) CA1335592C (sv)
DK (1) DK169723B1 (sv)
FI (1) FI96315C (sv)
HU (1) HU201757B (sv)
IL (1) IL89480A (sv)
MY (1) MY104955A (sv)
NO (1) NO170418C (sv)
NZ (1) NZ228299A (sv)
PT (1) PT89954B (sv)
WO (1) WO1989008654A1 (sv)
ZA (1) ZA891800B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
JPH06279444A (ja) * 1993-03-31 1994-10-04 Tokyo Tanabe Co Ltd インドリジン誘導体
US6084098A (en) 1999-02-26 2000-07-04 Neurogen Corporation Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
WO1999043670A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
US7696192B2 (en) * 2004-09-09 2010-04-13 Merck Sharp & Dohme Corp. Tricyclic anilide spirolactam CGRP receptor antagonists
ATE518852T1 (de) * 2004-09-13 2011-08-15 Merck Sharp & Dohme Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten
US7741317B2 (en) * 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
CN108853102B (zh) * 2017-05-15 2021-04-09 北京大学 作用于Dectin-1的稠合吖啶衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394373A (en) * 1972-05-17 1975-05-14 Pfizer Ltd Control of plant diseases
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
FR2567126B1 (fr) * 1984-07-06 1986-12-12 Synthelabo Derives de pyrrolo(1,2,3-de) benzoxazine et benzothiazine, leur preparation et leur application en therapeutique
JPS6317885A (ja) * 1986-07-11 1988-01-25 Kyorin Pharmaceut Co Ltd スピロピロリジン−２，５−ジオン誘導体の製造方法

Also Published As

Publication number Publication date
KR910002565B1 (ko) 1991-04-26
AU605410B2 (en) 1991-01-10
EP0332364A3 (en) 1991-04-03
FI96315C (sv) 1996-06-10
HU885829D0 (en) 1990-02-28
PT89954A (pt) 1989-11-10
JPH0676408B2 (ja) 1994-09-28
EP0332364A2 (en) 1989-09-13
DK169723B1 (da) 1995-01-23
NZ228299A (en) 1990-09-26
IL89480A0 (en) 1989-09-10
ZA891800B (en) 1990-10-31
NO170418B (no) 1992-07-06
IL89480A (en) 1994-04-12
CA1335592C (en) 1995-05-16
NO170418C (no) 1992-10-14
JPH01275580A (ja) 1989-11-06
HU201757B (en) 1990-12-28
DK116689A (da) 1989-09-12
DK116689D0 (da) 1989-03-10
KR890014545A (ko) 1989-10-24
WO1989008654A1 (en) 1989-09-21
MY104955A (en) 1994-07-30
FI96315B (sv) 1996-02-29
PT89954B (pt) 1994-05-31
NO894350D0 (no) 1989-11-01
NO894350L (no) 1989-11-01
AU3120489A (en) 1989-09-14

Similar Documents

Publication Publication Date Title
FI905941A (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat
FI890282A0 (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI96861C (sv) Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI890072A (sv) Förfarande för framställning av farmaceutiskt användbara isokinolinderivat
FI930723A0 (sv) Förfarande för framställning av terapeutiskt aktiva tiazolidinderivat
FI92696C (sv) Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat
FI900813A0 (sv) Förfarande för framställning av nya terapeutiskt användbara bensazepin- och bensotiazepinderivat
AU6613990A (en) Thiazolidine derivatives for the treatment of hypertension
NO864110L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
FI93444B (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
FI895333A0 (sv) Förfarande för framställning av terapeutiskt användbara pyrrolokinolin-, -bensotiazin-, -akridin-, -fenoxazin- och -fenotiazinderivat
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
HU891441D0 (en) Process for the preparation of novel 1,4-benzoxazine and 1,4-benzothiazine derivatives
FI893003A (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
HU895682D0 (en) Process for the preparation of optically active benzoxazines and benzothiazines
FI891111A (sv) Förfarande för framställning av 1,4-dihydropyridinderivat
FI893434A (sv) Förfarande för framställning av nya terapeutiskt användbara cykloalkyltiazolderivat
NO903397D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd.
FI89595B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-(tioalkylamino)etyl-1H-imidazolderivat
FI93010B (sv) Förfarande för framställning av 1,5-bensotiazepinderivat
FI894813A0 (sv) Förfarande för framställning av terapeutiskt aktiva 2-metoxikarbonylsubstituerade N,N'-di(trimetoxibensoyl)piperazinderivat
FI92393B (sv) Förfarande för framställning av 1,5-bensotiazepinderivat

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: PFIZER INC.